Searched for
PHARMACEUTICAL INDUSTRY EARNINGS
These mid-caps have ‘strong buy’ & ‘buy’ recos and an upside potential of over 25%, according to analystsWhat is needed in the markets these days is realism. Not fear or gloom, but a clear-eyed acceptance of where things actually stand. Realism...- Inside the deal engine room: VCs and PEs make the case for ERP as a governance variableAt an NTT DATA Business Solutions Pvt. Ltd. India roundtable, a cohort of leading VCs and PE investors argued that the maturity of a compan...
- Anupam Rasayan completes Bliss GVS deal, targets Rs 4,000-crore integrated platformAnupam Rasayan India Limited has finalised its acquisition of a controlling interest in Bliss GVS Pharma, marking a strategic expansion int...
- Market veterans favour value plays over crowded, expensive themesMarket experts project cautious optimism for Indian equities as valuations become less demanding and earnings growth aligns. Large-cap stoc...
- India’s FDI equity inflows rise 6% to $19.8 billion in Q1FY27; Japan tops, US plunges 76%India’s FDI equity inflows rose 6% to $19.81 billion in April-June FY27, led by Japan at $5.7 billion, while US inflows fell 76% to $1.34 b...
- MF Tracker: HDFC Pharma & Healthcare Fund tops equity MFs at 25% in 1 year. Should investors chase the rally?HDFC Pharma and Healthcare Fund recorded an impressive 25% return in the last year, surpassing its category average across various time fra...
- 5 stocks with consistent score improvement and upside potential of up to 22% in 1 year, according to analystsGiven the current situation both globally and domestically, one can expect more headwinds in the market. There is, on the domestic front, a...
- US stocks today: US stocks slip as Treasury yields rise, investors weigh Fed outlookUS stocks fell on Friday as higher Treasury yields, volatile oil prices and uncertainty over the Federal Reserve’s rate path weighed on sen...
- These large- and mid-cap stocks with ‘Strong Buy’ & ‘Buy’ recos have upside potential of up to 25%, according to analystsTalk of tariffs, especially steep ones, makes the market nervous. Which is exactly why the next few trading sessions are critical, and why ...
- JM Financial sees up to 28% upside in Dr Reddy’s and Aurobindo Pharma. Should you buy?JM Financial retained Buy ratings on Dr Reddy’s Laboratories and Aurobindo Pharma, seeing up to 28% upside over the next 12 months. The bro...
- For investors who know and accept that bears can roam the street longer: 5 mid-cap stocks with upside potential of up to 29%It is when the market displays the kind of sentiment it is doing now that most investors develop a strong desire to just get out. That’s qu...
- Smallcap, midcap stocks give 85 multibaggers but pro investors are betting elsewhereIn 2023, while small and mid-cap stocks experienced notable increases, a trend among professional investors is emerging towards largecap co...
- EV-related stocks: Own the chain, not the guess; 13 stocks with upside potential of up to 28% and downside risk of -14%, according to analystsIn the stock market, when a big theme or sectoral trend takes off, most investors focus on the face of it. A brand with which they can rela...
- $4 billion CIO Nimesh Chandan spots 4 bullish signals for Indian stocks. What changed?India’s stock market is poised for a broader recovery as four core cycles—macroeconomics, corporate earnings, credit growth, and market sen...
- Prasol Chemicals IPO Day 3: Check GMP, subscription status and other detailsPrasol Chemicals IPO enters its final bidding day with muted demand and zero GMP, pointing to expectations of a flat listing. The Rs 500 cr...
- Prasol Chemicals IPO Day 2: GMP, subscription status. Should you subscribe?Prasol Chemicals IPO saw 72% subscription by Day 2, with retail investors showing strong interest. The grey market premium remains modest a...
- Prasol Chemicals IPO opens for bidding. Check GMP and other key detailsThe Prasol Chemicals IPO opened for subscription on September 8 and will remain open until September 10. The Rs 500 crore issue comprises a...
- Glass, PET keep spirits high amid can shortageIndian beverage firms are increasingly using glass and PET bottles for packaging. This shift occurs as the West Asia conflict disrupts alum...
- Can Prasol Chemicals IPO deliver long-term growth for high-risk investors?Prasol Chemicals plans an IPO to raise funds for debt repayment and expansion. The company's revenue and profits have shown significant gro...
- Andhra man quits pharmaceutical industry after 25 years to grow Moringa. Turns leaves into a Rs 1,000/Kg product, earns Rs 15 lakh per acreAfter dedicating 25 years of his career to Dr Reddy's Laboratories, Annapureddy Prakash Reddy took a bold step back to his agricultural roo...
Load More
